-+ 0.00%
-+ 0.00%
-+ 0.00%

HYMPAVZI® (MARSTACIMAB) REDUCED BLEEDS BY 93% COMPARED TO ON-DEMAND TREATMENT IN ADULTS AND ADOLESCENTS WITH HEMOPHILIA A OR B WITH INHIBITORS

Reuters·12/06/2025 22:15:02

Please log in to view news